- Companies
- Genomic Valley Biotech
Genomic Valley Biotech Valuation Multiples
Genomic Valley Biotech is valued at $2M as of November 2026, a 54.8x revenue multiple. In the last fiscal year, Genomic Valley Biotech revenue was $28K and Genomic Valley Biotech EBITDA was $5K.
Genomic Valley Biotech Overview
About Genomic Valley Biotech
Genomic Valley Biotech is a listed Indian biotechnology company whose shares trade on the BSE. It was set up to carry out biotechnology research and to produce tissue-cultured plants, and it has been involved in commercial greenhouse cultivation of crops and in operating a plant tissue culture laboratory. The registered office is in the Bahadurgarh area of Jhajjar district, Haryana. The company has been adding human genomics activities, including next-generation sequencing based diagnostic services, oncology diagnostics, decision-support for doctors and personalised therapy options, and research process outsourcing services for researchers. Its income comes from horticultural and agricultural products and from diagnostic and research services. The business is small, with a promoter-led shareholder base and a modest public float.
Founded
1994
HQ
Employees
3
Website
Financials (Last FY)
EV
$2M
Valuation Multiples
Start free trialGenomic Valley Biotech Financials
Genomic Valley Biotech reported last fiscal year revenue of $28K and EBITDA of $5K.
In the same fiscal year, Genomic Valley Biotech generated $28K in gross profit, $5K in EBITDA, and $3K in net income.
Genomic Valley Biotech P&L
In the most recent fiscal year, Genomic Valley Biotech reported revenue of $28K and EBITDA of $5K.
Genomic Valley Biotech is profitable as of last fiscal year, with gross margin of 100%, EBITDA margin of 16%, and net margin of 11%.
Financial data powered by Morningstar, Inc.
Genomic Valley Biotech Stock Performance
Genomic Valley Biotech has current market cap of $2M, and enterprise value of $2M.
Market Cap Evolution
Genomic Valley Biotech's stock price is $0.53.
Genomic Valley Biotech share price increased by 5.2% in the last 30 days.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2M | $2M | 5.2% | 5.2% | - | - | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGenomic Valley Biotech Valuation Multiples
Genomic Valley Biotech trades at 54.8x EV/Revenue multiple, and 335.2x EV/EBITDA.
Genomic Valley Biotech Financial Valuation Multiples
As of November 3, 2026, Genomic Valley Biotech has market cap of $2M and EV of $2M.
Genomic Valley Biotech has a P/E ratio of 509.0x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Genomic Valley Biotech Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Genomic Valley Biotech Margins & Growth Rates
In the most recent fiscal year, Genomic Valley Biotech reported gross margin of 100%, EBITDA margin of 16%, and net margin of 11%.
Genomic Valley Biotech Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
Genomic Valley Biotech Operational KPIs
Genomic Valley Biotech's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Genomic Valley Biotech Competitors
Genomic Valley Biotech competitors include Glia Nova, Chromosome Dynamics, Virax Biolabs Group, Lifeline Biotechnologies, Edible Garden, Chucarapi, Above Food, PRFoods, 2cureX and AgroGalaxy.
Most Genomic Valley Biotech public comparables operate across Agriculture and Diagnostics & Genomics.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | ($57K) | - | - | (30.7x) | - | |||
| - | - | - | - | - | - | |||
| $12K | ($5M) | - | - | - | - | |||
| - | - | - | - | - | - | |||
| $13M | ($13M) | 1.7x | 1.4x | (1.7x) | - | |||
| - | - | - | - | - | - | |||
| $264M | ($28M) | 0.0x | - | (0.1x) | - | |||
| $15M | $57K | 0.7x | - | 196.2x | - | |||
This data is available for Pro users. Sign up to see all Genomic Valley Biotech competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Genomic Valley Biotech
| When was Genomic Valley Biotech founded? | Genomic Valley Biotech was founded in 1994. |
| Where is Genomic Valley Biotech headquartered? | Genomic Valley Biotech is headquartered in India. |
| How many employees does Genomic Valley Biotech have? | As of today, Genomic Valley Biotech has over 3 employees. |
| Is Genomic Valley Biotech publicly listed? | Yes, Genomic Valley Biotech is a public company listed on Bombay Stock Exchange. |
| What is the stock symbol of Genomic Valley Biotech? | Genomic Valley Biotech trades under 539206 ticker. |
| When did Genomic Valley Biotech go public? | Genomic Valley Biotech went public in 2015. |
| Who are competitors of Genomic Valley Biotech? | Genomic Valley Biotech main competitors include Glia Nova, Chromosome Dynamics, Virax Biolabs Group, Lifeline Biotechnologies, Edible Garden, Chucarapi, Above Food, PRFoods, 2cureX, AgroGalaxy. |
| What is the current market cap of Genomic Valley Biotech? | Genomic Valley Biotech's current market cap is $2M. |
| What is the current revenue of Genomic Valley Biotech? | Genomic Valley Biotech's last fiscal year revenue is $28K. |
| What is the current EV/Revenue multiple of Genomic Valley Biotech? | Current revenue multiple of Genomic Valley Biotech is 54.8x. |
| Is Genomic Valley Biotech profitable? | No, Genomic Valley Biotech is not profitable. |
| How many companies Genomic Valley Biotech has acquired to date? | Genomic Valley Biotech hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Genomic Valley Biotech has invested to date? | Genomic Valley Biotech hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Genomic Valley Biotech
Lists including Genomic Valley Biotech
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




